Neff N F, Chamberlin M J
Biochemistry. 1980 Jun 24;19(13):3005-15. doi: 10.1021/bi00554a027.
Both bacteriophage T7 and the related bacteriophage T3 have strong termination sites for bacterial RNA polymerase located near 20% on the standard genome map. These termination sites are used with 90% efficiency in vivo, even in cells which contain a defective p protein. Under normal reaction conditions in vitro, Escherichia coli RNA polymerase terminates with 90% efficiency at the T7 terminator site but shows little or no termination at the corresponding T3 locus. Thus, the two templates form an ideal in vitro test system with which to study the parameters that govern transcriptional termination. Termination at these sites has been monitored by following the time course of RNA synthesis under conditions where only a single transcriptional cycle is carried out and by following the size distribution of RNA chains by gel electrophoresis. Termination of the T7 termination site is unaffected by a large variety of changes in reaction conditions, by quantitative cleavage of the nascent RNA during the reaction with a mixture of single- and double-stranded specific ribonucleases, or by a number of different mutations in the subunits of RNA polymerase, including sigma. Similarly, a large variety of changes in reaction conditions fail to enhance termination at the T3 terminator site, including changes in temperature, MgCl2 concentration, and glycerol concentration or the addition of dimethyl sulfoxide, ethanol, or spermidine to the reaction. However, in the presence of elevated salt concentrations, at low ribonucleoside triphosphate concentrations, and in the presence of formamide, efficient in vitro utilization of the T3 terminator is seen. Changes in the RNA polymerase protein can also enhance utilization of the T3 site. A class of rifampicin-resistant rpoB mutants has been identified which produce a rifampicin-resistant RNA polymerase which is able to utilize the T3 terminator site in vitro. Similarly, the normal Bacillus subtilits RNA polymerase utilizes the T3 terminator site in vitro with high efficiency.
噬菌体T7和相关噬菌体T3在标准基因组图谱上靠近20%的位置都有细菌RNA聚合酶的强终止位点。这些终止位点在体内的使用效率为90%,即使在含有缺陷p蛋白的细胞中也是如此。在体外正常反应条件下,大肠杆菌RNA聚合酶在T7终止位点的终止效率为90%,但在相应的T3位点几乎不终止或不终止。因此,这两种模板形成了一个理想的体外测试系统,可用于研究控制转录终止的参数。在仅进行单个转录循环的条件下,通过跟踪RNA合成的时间进程,并通过凝胶电泳跟踪RNA链的大小分布,来监测这些位点的终止情况。T7终止位点的终止不受多种反应条件变化的影响,不受反应过程中用单链和双链特异性核糖核酸酶混合物对新生RNA进行定量切割的影响,也不受RNA聚合酶亚基(包括sigma)中许多不同突变的影响。同样,多种反应条件的变化也无法增强T3终止位点的终止,包括温度、MgCl2浓度、甘油浓度的变化,或向反应中添加二甲基亚砜、乙醇或亚精胺。然而,在盐浓度升高、核糖核苷三磷酸浓度较低以及存在甲酰胺的情况下,可以看到T3终止子在体外的有效利用。RNA聚合酶蛋白的变化也可以增强T3位点的利用。已经鉴定出一类耐利福平的rpoB突变体,它们产生一种耐利福平的RNA聚合酶,该酶能够在体外利用T3终止位点。同样,正常的枯草芽孢杆菌RNA聚合酶在体外也能高效利用T3终止位点。